The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Glaucoma and its treatment: A review
Abstract
PURPOSE: A review of glaucoma and its treatment is presented. SUMMARY: Glaucoma is a common eye disease that can cause irreversible blindness if left undiagnosed and untreated. Glaucoma is a leading cause of blindness in the United States and other industrialized countries. In most cases, the symptoms of early-stage glaucoma are minimal or nonexistent. There are several different types of glaucoma, and they have been classically divided into the categories of primary or secondary open-angle or angle-closure glaucoma. Secondary forms of glaucoma are caused by various ocular or systemic diseases. Every available treatment to prevent progressive glaucomatous optic neuropathy has potential adverse effects and involves a certain amount of risk and financial expense. Conventional first-line treatment of glaucoma usually begins with the use of a topical selective or nonselective beta-blocker or a topical prostaglandin analog. Second-line drugs of choice include alpha-agonists and topical carbonic anhydrase inhibitors. Parasympathomimetic agents, most commonly pilocarpine, are considered third-line treatment options. For patients who do not respond to antiglaucoma medications, laser trabeculoplasty and incisional surgery are further methods that can be used to lower intraocular pressure. The results of clinical trials have reaffirmed the utility of antiglaucoma medications in slowing the progression of the disease. CONCLUSION: Glaucoma is a common eye disease that is usually associated with an elevated intraocular pressure. Treatment options for patients with glaucoma include medications, laser therapy, and incisional surgery. The risks and benefits of each type of treatment must be carefully considered to maximize the treatment's benefits while minimizing adverse effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kass, M. A. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.6.701 · Cited by 3,705
Heijl, A. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.10.1268 · Cited by 3,320
Factors for Glaucoma Progression and the Effect of Treatment: The Early Manifest Glaucoma Trial
Leske, M. C. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.1.48 · Cited by 2,030
Leibowitz, H. M., Krueger, D. E., Maunder, L. R., Milton, R. C., KINI, M. M., Kahn, H. A., Nickerson, R. J., Pool, J., Colton, T., Ganley, J. P., et al. (1980) · PubMed · Cited by 1,250
Lichter, P. (2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00873-9 · Cited by 1,178
Prevalence of Open-Angle Glaucoma Among Adults in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.532 · Cited by 1,110
Racial Variations in the Prevalence of Primary Open-angle Glaucoma: The Baltimore Eye Survey
Tielsch, J. M. (1991) · JAMA · doi:10.1001/jama.1991.03470030069026 · Cited by 879
Risk factors for progression of visual field abnormalities in normal-tension glaucoma
Drance, S., Anderson, D. R., & Schulzer, M. (2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)00964-3 · Cited by 790
Models of open-angle glaucoma prevalence and incidence in the United States.
Quigley, H. A., & Vitale, S. (1997) · PubMed · Cited by 379
National Survey of the Prevalence and Risk Factors of Glaucoma in St. Lucia, West Indies
Mason, R. P., Kosoko, O., Wilson, M. R., Martone, J. F., Cowan, C. L., Gear, J. C., & Ross-Degnan, D. (1989) · Ophthalmology · doi:10.1016/s0161-6420(89)32708-4 · Cited by 313
A Case-Control Study of Risk Factors in Open Angle Glaucoma
Wilson, M. R., Hertzmark, E., Walker, A. M., Childs-Shaw, K., & Epstein, D. L. (1987) · Archives of Ophthalmology · doi:10.1001/archopht.1987.01060080068030 · Cited by 310
(2004) · Ophthalmology · doi:10.1016/j.ophtha.2003.09.025 · Cited by 309
Kupper, C. (1980) · Survey of Ophthalmology · doi:10.1016/0039-6257(80)90015-6 · Cited by 246
Janz, N. (2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00874-0 · Cited by 223
Hypertension, diabetes, and longitudinal changes in intraocular pressure
Hennis, A., Wu, S.-Y., Nemesure, B., & Leske, M. C. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00075-7 · Cited by 219
The advanced glaucoma intervention study (AGIS): 4. comparison of treatment outcomes within race
(1998) · Ophthalmology · doi:10.1016/s0161-6420(98)97013-0 · Cited by 174
Race and Primary Open-Angle Glaucoma
Martin, M. J., Summer, A., Gold, E. B., & Diamond, E. L. (1985) · American Journal of Ophthalmology · doi:10.1016/0002-9394(85)90001-7 · Cited by 161
The Ocular Hypertension Treatment Study
Higginbotham, E. J. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.6.813 · Cited by 153
Self-citationHeritability of Risk Factors for Primary Open-Angle Glaucoma: The Beaver Dam Eye Study
Klein, R., Klein, R., & Lee, K. E. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0516 · Cited by 143
Racial influences in open-angle glaucoma.
Wilensky, J. T., Gandhi, N., & Pan, T. (1978) · PubMed · Cited by 84
Factors related to the 4-year risk of high intraocular pressure: the Barbados Eye Studies.
Nemesure, B. B., Wu, S.-Y., Hennis, A., & Leske, M. C. (2003) · PubMed · doi:10.1001/archopht.121.6.856 · Cited by 60
Chen, H., Kung, H.-J., & Robinson, D. R. (1998) · Journal of Biomedical Science · doi:10.1007/bf02258361 · Cited by 13
Cited by
Glaucoma treatment trends: a review
Conlon, R., Saheb, H., & Ahmed, I. I. K. (2017) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2016.07.013 · Cited by 344
Coated Microneedles for Drug Delivery to the Eye
Jiang, J., Gill, H. S., Ghate, D., McCarey, B. E., Patel, S. R., Edelhauser, H. F., & Prausnitz, M. R. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0066 · Cited by 286
PGC-1α signaling coordinates susceptibility to metabolic and oxidative injury in the inner retina
Guo, X., Dason, E. S., Zanon-Moreno, V., Jiang, Q., Nahirnyj, A., Chan, D., Flanagan, J. G., & Sivak, J. M. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.12.012 · Cited by 47
Metadata
- Authors
- Lee, D. A., & Higginbotham, E. J.
- Venue
- American Journal of Health-System Pharmacy
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-04-01
- Volume
- 62
- Issue
- 7
- Pages
- 691-699
- ISSN
- 1079-2082 (ISSN-L)
- 1535-2900
- OpenAlex
- W1962217919
- Cited by
- 317
- References
- 22
- FWCI
- 8.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.